Year |
Citation |
Score |
2023 |
Brady PB, Sorensen BK, Risi RM, Curtin ML, Mantei RA, Florjancic AS, Mastracchio A, Ji C, Kunzer AR, Lai C, Storer GE, Chan VS, Henry RF, Souers AJ, Michaelides MR, et al. Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467. The Journal of Organic Chemistry. PMID 37909857 DOI: 10.1021/acs.joc.3c00939 |
0.367 |
|
2018 |
Bromberg KD, Lasko LM, Jakob CG, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey RR, Manaves V, Shaw B, Algire M, Hessler P, Lam LT, Uziel T, et al. Abstract LB-A23: Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Lb-A23 |
0.327 |
|
2015 |
Risi RM, Maza AM, Burke SD. Asymmetric hydroformylation-initiated tandem sequences for syntheses of (+)-patulolide C, (-)-pyrenophorol, (+)-decarestrictine L, and (+)-prelog djerassi lactone. The Journal of Organic Chemistry. 80: 204-16. PMID 25398097 DOI: 10.1021/Jo502301K |
0.603 |
|
2012 |
Risi RM, Burke SD. Synthesis of the Prelog-Djerassi lactone via an asymmetric hydroformylation/crotylation tandem sequence. Organic Letters. 14: 2572-5. PMID 22559226 DOI: 10.1021/Ol3008765 |
0.587 |
|
2012 |
Risi RM, Burke SD. Synthesis of (+)-patulolide C via an asymmetric hydroformylation/macrocyclization cascade. Organic Letters. 14: 1180-2. PMID 22304535 DOI: 10.1021/Ol2034299 |
0.582 |
|
Show low-probability matches. |